 |
|
|
| |
Simplification to Atazanavir/Ritonavir + Lamivudine versus Maintaining Atazanavir/Ritonavir + 2NRTIs in Virologically Suppressed HIV-infected Patients: 48-weeks Data of the ATLAS-M Trial
|
| |
| |
Reported by Jules Levin
EACS 2015 Oct 21-24 Barcelona, Spain - 15th European AIDS Conference
S. Di Giambenedetto1, M. Fabbiani1, E. Quiros-Roldan2, A. Latini3, G. D'Ettorre4, A. Antinori5, A. Castagna6, G. Orofino7, D. Francisci8, P. Chinello9, G. Madeddu10, P. Grima11, S. Rusconi12, B. Del Pin13, A. Mondi1, A. Borghetti1, F. Castelli2, M. Colafigli3, A. De Luca1,14, R. Cauda1, ATLAS-M Study Group
1Catholic University of Sacred Heart, Institute of Clinical Infectious Diseases, Rome, Italy, 2University of Brescia, University Division of Infectious and Tropical Diseases, Brescia, Italy, 3IFO S. Gallicano Institute (IRCCS), Infectious Dermatology and Allergology Unit, Rome, Italy, 4'La Sapienza' University, Department of Infectious Diseases, Rome, Italy, 5National Institute for Infectious Diseases 'Lazzaro Spallanzani' IRCCS, Rome, Italy, 6Vita-Salute San Raffaele University, San Raffaele Hospital, Department of Infectious and Tropical Diseases, Milan, Italy, 7Amedeo di Savoia Hospital, Infectious and Tropical Diseases Unit, Turin, Italy, 8University of Perugia, Infectious Diseases Clinic, Perugia, Italy, 9National Institute for Infectious Diseases 'Lazzaro Spallanzani' IRCCS, Systemic Infections and Immunodeficiency Unit, Rome, Italy, 10University of Sassari, Department of Clinical and Experimental Medicine, Sassari, Italy, 11'S. Caterina Novella' Hospital, Division of Infectious Diseases, Galatina, Italy, 12DIBIC Luigi Sacco, University of Milan, Infectious Diseases Unit, Milan, Italy, 13S.M. Annunziata Hospital, Unit of Infectious Diseases, Florence, Italy, 14Siena University Hospital, Infectious Diseases Unit, Siena, Italy
|
| |
|
|
|
|
|
